1201 Maryland Avenue, SW
Suite 900
Washington, DC 20024
Please join BIO and PhRMA for a discussion focusing on biologics, biosimilars and the Biosimilar User Fee Act (BsUFA). A biosimilar is a biological product that is approved based on a showing that it is highly similar to an already approved biological product, known as a reference biological product.